Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 22 of 22 entries
View as:

Dose-range Finding Treosulfan-based Conditioning

Phase: N/A Priority: Normal
NCT ID: NCT01063647 Org: User:
Start: 11/30/01 End: 06/30/06 Due: 06/30/07

Bioavailability in Patient With Psoriasis: Metoject Prefilled Pen

Phase: N/A Priority: Normal
NCT ID: NCT02097173 Org: User:
Start: 05/31/13 End: - Due: -

Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02349906 Org: User:
Start: 04/30/15 End: 04/30/23 Due: 04/30/24

Preference Methotrexate (MTX) Pre-filled Syringe Versus Pre-filled Pen in Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01793259 Org: User:
Start: 07/31/12 End: 06/30/13 Due: 06/30/14

Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02052167 Org: User:
Start: 04/30/14 End: 08/31/14 Due: 08/31/15

PK, PD, Safety and Immunogenicity of Spectrila in Adults with Acute B-cell Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT03156790 Org: User:
Start: 04/26/19 End: 05/31/26 Due: 05/31/27

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT02755142 Org: User:
Start: 02/29/00 End: 06/30/01 Due: 06/30/02

Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT06239311 Org: User:
Start: 02/27/24 End: 03/31/26 Due: 03/31/27

Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient

Phase: N/A Priority: Normal
NCT ID: NCT01871961 Org: User:
Start: 10/31/12 End: 05/31/13 Due: 05/31/14

Urokinase Therapy in Patients With Diabetic Foot Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00823225 Org: User:
Start: 06/30/08 End: 06/30/09 Due: 06/30/10

Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT01063660 Org: User:
Start: 03/31/04 End: 07/31/07 Due: 07/31/08

Treatment of Steroid-Refractory Acute Graft-versus-host Disease with Mesenchymal Stromal Cells Versus Best Available Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04629833 Org: User:
Start: 08/16/21 End: 08/31/30 Due: 08/31/31

Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT00983138 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

Effect of Moderate Renal Impairment and Race/Ethnicity on Treosulfan Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT05534620 Org: User:
Start: 02/01/24 End: 12/31/25 Due: 12/31/26

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02333058 Org: User:
Start: 11/21/14 End: 09/30/19 Due: 09/30/20

Urokinase Therapy in Diabetic Foot Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00537498 Org: User:
Start: 02/28/02 End: 12/31/06 Due: 12/31/07

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Phase: N/A Priority: Normal
NCT ID: NCT00822393 Org: User:
Start: 11/24/08 End: 01/25/18 Due: 01/25/19

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT00784017 Org: User:
Start: 10/31/08 End: 10/31/12 Due: 10/31/13

Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid

Phase: N/A Priority: Normal
NCT ID: NCT00241670 Org: User:
Start: 10/31/99 End: - Due: -

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01062490 Org: User:
Start: 11/30/04 End: 10/31/09 Due: 10/31/10

Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia

Phase: N/A Priority: Normal
NCT ID: NCT01251809 Org: User:
Start: 01/31/11 End: 05/31/13 Due: 05/31/14

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants with Steroid-Refractory Acute Graft Versus Host Disease

Phase: N/A Priority: Normal
NCT ID: NCT06075706 Org: User:
Start: 11/13/23 End: 06/30/31 Due: 06/30/32